India can help solve the accessibility problem of breakthrough cancer treatment CAR -T Cell therapy, according to American physician scientist Carl June.
CAR-T therapies have been effective against certain types of blood cancer. However, the treatment remained inaccessible to most patients due to its cost.
The CAR-T therapy costs about $1 million - $1.5 million, including administration and hospitalisation costs in US.
Novartis charges Kymriah - its CAR-T therapy about $475,000 for acute lymphoblastic leukemia (ALL).